Our Strategy

Clinical Services

The L-asparaginase assay is a laboratory developed test (LDT) to determine the enzyme activity of L-asparaginase in patients who have been treated with Elspar®/Kidrolase®, Oncaspar®, or Erwinaze®. This assay has been validated and is performed in our CLIA certified laboratory to monitor the asparaginase activity level during a patient’s treatment.

 

Because our genetic makeup is not all the same, the way that we each metabolize medications is not all the same.  NEXT Molecular Analytics provides genetic testing to supply to a physician to guide treatment of their patients.

 

 

Please reload

© 2015 NEXT Molecular Analytics - <SID>

  • LinkedIn Social Icon
  • Twitter Social Icon
  • Facebook Social Icon